Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review)
Nobunao Ikewaki
, Vidyasagar Devaprasad Dedeepiya
, Kadalraja Raghavan
, Kosagi Sharaf Rao
, Suryaprakash Vaddi
, Hiroshi Osawa
, Tomohiko Kisaka
, Gene Kurosawa
, Subramaniam Srinivasan
, Seydunganallu Ramasamy Balaganesa Kumar
, Rajappa Senthilkumar
, Masaru Iwasaki
, Senthilkumar Preethy
, Samuel J.K. Abraham
International Center for Cell and Gene Therapy
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer Therapy
100%
Immunity
100%
Glucan
100%
Vaccine Adjuvant
100%
Immune System
40%
Diabetes
20%
Disease
20%
Side Effect
20%
Cytotoxicity
20%
Radiation Therapy
20%
Blood Cell
20%
Blood Glucose
20%
Weakness
20%
Biological Response Modifier
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Glucan
100%
Vaccine Adjuvant
100%
Chemotherapy
33%
Disease
16%
Cytotoxicity
16%
Side Effect
16%
Weakness
16%
Biological Response Modifier
16%
Keyphrases
Immunocompromised Population
100%
System Weaknesses
33%
Microinflammation
33%